Difference between revisions of "FNSGp"
From Bioblast
(Created page with "{{MitoPedia |abbr=FNSGp |description='''FNSGp''': Octanoylcarnitine or Palmitoylcarnitine & Pyruvate &/or Glutamate & Malate & Succinate & Glyceropho...") Β |
|||
Line 1: | Line 1: | ||
{{MitoPedia | {{MitoPedia | ||
|abbr=FNSGp | |abbr=FNSGp | ||
|description= | |description=[[Image:SUIT-catg_FNSGp.jpg|right|400px|Convergent electron flow]] | ||
'''MitoPathway control state:''' FNSGp | '''MitoPathway control state:''' FNSGp Β | ||
:[[Octanoylcarnitine]] or [[Palmitoylcarnitine]] & [[Pyruvate]] &/or [[Glutamate]] & [[Malate]] & [[Succinate]] & [[Glycerophosphate]]. | |||
'''SUIT protocol:''' [[SUIT-002]] | '''SUIT protocol:''' [[SUIT-002]] | ||
Line 9: | Line 10: | ||
This substrate combination supports convergent electron flow to the [[Q-junction]]. | This substrate combination supports convergent electron flow to the [[Q-junction]]. | ||
|info=[[MiPNet21.06 SUIT reference protocol]] | |info=[[MiPNet21.06 SUIT reference protocol]], [[Gnaiger 2014 MitoPathways]] | ||
}} | }} | ||
{{MitoPedia concepts | {{MitoPedia concepts | ||
|mitopedia concept=SUIT state | |mitopedia concept=SUIT state | ||
}} | }} | ||
::: ''More details'' | |||
::::Β» [[Additive effect of convergent electron flow]] | |||
::::Β» [[Respiratory_complexes#Respiratory_complexes_-_more_than_five |Respiratory complexes - more than five]] | |||
::::Β» [[OctPGMSGp pathway control state]] | |||
::::Β» [[Convergent electron flow]] | |||
== FNSGp pathway in the LEAK state can be evaluated in the following SUIT protocols == | |||
== FNSGp( | == FNSGp pathway in the OXPHOS state can be evaluated in the following SUIT protocols == | ||
:::*[[SUIT-002]] | |||
::::*Mt-preparation: | |||
:::::*[[SUIT-002 O2 mt D005]] | |||
::::* Permeabilized fibers (pfi): | |||
:::::*[[SUIT-002 O2 pfi D006]] | |||
::::*Permeabilized cells (pce): | |||
:::::*[[SUIT-002 O2 pce D007]] | |||
== FNSGp | == FNSGp pathway in the ET state can be evaluated in the following SUIT protocols == | ||
:::[[SUIT-002 | :::*[[SUIT-002]] | ||
::::*Mt-preparation: | |||
::: | :::::*[[SUIT-002 O2 mt D005]] | ||
:::[[SUIT-002 O2 mt D005]] | ::::* Permeabilized fibers (pfi): | ||
:::[[SUIT-002 O2 pfi D006]] | :::::*[[SUIT-002 O2 pfi D006]] | ||
:::[[SUIT-002 O2 pce D007]] | ::::*Permeabilized cells (pce): | ||
:::::*[[SUIT-002 O2 pce D007]] | |||
Revision as of 12:22, 22 January 2019
Description
MitoPathway control state: FNSGp
- Octanoylcarnitine or Palmitoylcarnitine & Pyruvate &/or Glutamate & Malate & Succinate & Glycerophosphate.
SUIT protocol: SUIT-002
This substrate combination supports convergent electron flow to the Q-junction.
Abbreviation: FNSGp
Reference: MiPNet21.06 SUIT reference protocol, Gnaiger 2014 MitoPathways
MitoPedia concepts:
SUIT state
FNSGp pathway in the LEAK state can be evaluated in the following SUIT protocols
FNSGp pathway in the OXPHOS state can be evaluated in the following SUIT protocols
-
- Mt-preparation:
- Permeabilized fibers (pfi):
- Permeabilized cells (pce):
-
FNSGp pathway in the ET state can be evaluated in the following SUIT protocols
- Mt-preparation:
- Permeabilized fibers (pfi):
- Permeabilized cells (pce):